Skip to main content

AB22002 - A dose-ranging study to investigate efficacy and safety of buntanetap in participants with early AD

Clinical Trial Grant
Duke Scholars

Administered By

Duke Clinical Research Institute

Awarded By

Annovis Bio, Inc.

Start Date

December 7, 2022

End Date

June 23, 2024
 

Administered By

Duke Clinical Research Institute

Awarded By

Annovis Bio, Inc.

Start Date

December 7, 2022

End Date

June 23, 2024